Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Pharmacological Action of Adenosine on the Cardiovascular System

Adenosine의 심장 및 혈관에 대한 약리작용

  • Received : 2010.12.21
  • Accepted : 2011.03.25
  • Published : 2011.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Bolus intravenous injection of adenosine resulted the temporal decrease of systemic blood pressure and heart rate in the anesthetized rats. Adenosine also resulted the persistent decrease of contractility and heart rate in the isolated spontaneously beating rat right atria. Both of the above inhibition effets of adenosine were increased by the pretreatment of NBI (nitrobenzylthioinosine), whitch is an adenosine transport inhibitor, but decreased by the pretreatment of 8- phenyltheophy1line, which is an adenosine antagonist. In isolated thoracic aorta ring segment of normotensive rats, intact rings were relaxed by adenosine ($42.3{\pm}8.7%$) and ATP ($85.9{\pm}15.8%$) in the concentration of $10^{-4}M$, but rubbed rings were relaxed by adenosine ($35.2{\pm}1.9%$) and ATP ($11.3{\pm}9.0%$) in $10^{-4}M$. After pretreatment of L-NAME (N-Nitro-Larginine methyl ester), which is an NO inhibitor, adenosine-induced relaxation was not affected, but ATP-induced relax ation was significantly inhibited (P<0.01). Meanwhile, adenosine resulted almost same as vasorelaxation in isolated thoracic aorta of SHR comparing to those of normotensive rats. But, vasodilation responses of ATP in intact rings of SHR are significantly inhibited comparing to those of normotensive rats. Adenosine-induced relaxation is attenuated after 8-phenyltheophylline pretreatment, but increased after NBI pretreatment. However, ATP-induced relaxations are not affected by 8-phenyltheophylline or NBI pretreatment. These results suggested that the hypotensive effects of adenosine was due to the decrease of contractile force and heart rate through the A1 receptor and vasodilation are mediated by A2 receptor of the vascular smooth muscle. And, the heart protective and vasodilation effects of adenosine might suggest that it would be useful in the acute treatment of coronary artery disease.

Keywords

References

  1. Tasatargil A, Sadan G, Karasu E, Ozdem S. Changes in atrium and thoracic aorta reactivity to adenosinergic and adrenergic agonists in experimental hyperhomocysteinemia. J Cardiovasc Pharmacol 2006; 47(5): 673-9. https://doi.org/10.1097/01.fjc.0000211756.31820.17
  2. Urmallya VB, Pouton CW, Devine SM, Haynes JM, Warfe L, Scammells PJ, White PJ. A novel highly selective adenosine A1 receptor agonist VCP28 reduces ischemia injury in a cardiac cell line and ischemia-reperfusion injury in isolated rat hearts at concentrations that do not affect heart rate. J cardiovasc Pharmacol 2010; 56(3): 282-92. https://doi.org/10.1097/FJC.0b013e3181eb8563
  3. Burnstock, G. A basis of distinguishing two types of purinergic receptors, In: Bolis L, Straub RW, eds. Cell Membrene Receptors for Drugs and Hormones. New York, Raven, 1978; 107-11.
  4. Londos D, Cooper DMF, Schlegel W. Adenosine analog inhibit adipocyte adenylate cyclase by a GTP-dependent process:Basis for action of adenosine and methylxanthines of cyclic AMP productions and lipolysis. Proc Natl Acad Sci USA 1978; 75, 5362-67. https://doi.org/10.1073/pnas.75.11.5362
  5. Van Calker D, Muller M, Hamprecht B, Adenosine regulates, via two different types of receptor, the accumulation of cyclic AMP in cultured cells. J Neurochem 1979; 33, 999-1006. https://doi.org/10.1111/j.1471-4159.1979.tb05236.x
  6. Mustafa SJ, Morrison RR, Teng B, Pelleg A. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol 2009; 193: 161-88.
  7. Tikh EI, Fenton RA, Dobson JG Jr. Contractile effects of adenosine A1 and A2A receptors in isolated hearts. Am J Physiol heart Circ Physiol 2006; 290(1): H348-56. https://doi.org/10.1152/ajpheart.00740.2005
  8. Belardinelli L, Linden J, Berne R, The cardiac effects of adenosine. Prog Cardiovasc Dis 1989; 32, 73-9. https://doi.org/10.1016/0033-0620(89)90015-7
  9. Sato A, Terata K, Miura H, Toyama K, Loberiza FR Jr, Hatoum OA, Saito T, Sakuma I, Gutterman DD. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Am J Physiol Heart Circ Physiol 2005; 288(4): H1633-40. https://doi.org/10.1152/ajpheart.00575.2004
  10. Teng B, Ledent C, Mustafa SJ. Up-regulation of A 2Badenosine receptor in A 2A adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol 2008; 44(5): 905-14. https://doi.org/10.1016/j.yjmcc.2008.03.003
  11. Nakazawa T, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K. Vasodilator effects of adenosine on retinal arterioles in streptozotosin-induced diabetic rats. Naunyn Schmiedergs Arch Pharmacol 2008; 376(6): 423-30. https://doi.org/10.1007/s00210-007-0233-z
  12. Gordon JL, Martin W, Endothelium-dependant relaxation of the pig aorta : relationship to stimulation of Rb efflux from isolated endothelial cells. Br pharmacol 1983; 79: 531-541. https://doi.org/10.1111/j.1476-5381.1983.tb11028.x
  13. Fruchgott RF. In: Vanhoutte PM, ed. Mechanism of vasodilators. New York: Raven Press, 1988; 401-414.
  14. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G, Endothelium derived relaxing factor produced and releases from artrey and vein is nitric oxide. Proc Nat1 Acad Sci USA 1987; 84: 9265-9. https://doi.org/10.1073/pnas.84.24.9265
  15. Jenner TL, Rose'Meyer RB. Adenosine A(3) receptor mediated coronary vasodiation in the rat heart: changes that occur with maturation. Mech Ageing Dev 2006; 127(3): 264-73. https://doi.org/10.1016/j.mad.2005.10.005
  16. Honey AC, Bland-Ward PA, Conner HE, Fenluk W, Humphrey PP. Study of an adenosine A1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat. Cephalalgia 2002; 22(4): 260-4. https://doi.org/10.1046/j.1468-2982.2002.00345.x
  17. Hocher B. Adenosine A1 receptor antagonists in clinical research and development 2010; 78(5): 438-45.
  18. Paterson ARP, Lau EY, Dahli E, Cass CE, A common basis for inhibition of nucleoside transport by dipyridmole and nitrobenzylthioinosine. Mol Pharmacol 1980; 18: 40-8.
  19. Harrington LS, Evans RJ, Wray J, Norling L, Swales KE, Vial C, Ali F, Carrier MJ, Mitchell JA. Purinergic 2X1 receptors mediate endothelial dependent vasodilation to ATP. Mol Pharmacol 2007; 72(5): 1132-6. https://doi.org/10.1124/mol.107.037325